Mitchell Eisenberg, MD co-founded Sheridan Healthcare in 1994. He has served on the board of directors since inception and as its chairman and CEO from 1994 to November 2012. From November 2012 until November 2013 he served as its executive chairman and then as a director until the completion of the merger of Sheridan into AmSurg in July 2014. During his tenure as chairman and CEO, Dr. Eisenberg was instrumental in their multiple financial transactions, including an IPO in 1995 and four separate private equity transactions, including TA Associates, Vestar Capital Partners, JW Childs and Hellman and Friedman. Under his leadership as CEO, Sheridan Healthcare grew from a single local practice to a national company in 23 states.
Since 2006, Dr. Eisenberg serves on the Foundation Boards of Memorial Hospital and Joe DiMaggio Childrenâ€™s Hospital, both of which are in Hollywood, Florida. He served as chairman of both foundation boards from 2011â€“2014 and currently sits on the executive committee of each as the immediate past chair.
In November 2012, Dr. Eisenberg co-founded EG Advisors, LLC. On December 19, 20l3, he co-founded Advanced Recovery Systems (ARS), an integrated behavioral health company specializing in the treatment of alcohol and drug abuse, eating disorders, and associated mental health issues. He is currently co-CEO and co-chairman of ARS, partnering with Goldman Sachs private equity in this entity. Dr. Eisenberg also serves as an operating partner for J.W. Childs Fund IV since March 2014.
Dr. Eisenberg graduated cum laude from Muhlenberg College in 1972. He received his M.D. from the Medical College of Pennsylvania in 1976,the same year he was elected into Alpha Omega Alpha (AOA), the national medical honor society. Dr. Eisenberg completed his residency in internal medicine at New England Deaconess Hospital and his anesthesia residency at Massachusetts General Hospital. Both programs are associated with Harvard Medical School. Dr. Eisenberg is board certified in both internal medicine and anesthesiology.